Compound Detail
CHEMBL4756775
Enter ChEMBL ID:
Free Research Context
This compound will appear in recent viewed items on the research home for this browser.
Research home
View demo workspace
Basic Information
| ChEMBL ID | CHEMBL4756775 |
| Phase | Preclinical |
| Structure Type | MOL |
| InChI Key | HTDCXHGZMOAJPP-UHFFFAOYSA-N |
1
Targets
2
Activities
1
Assay Types
0
PK Parameters
1
Publications
0
Known Names
Molecular Properties
325.3
MW (Da)
1.07
ALogP
5
HBA
4
HBD
111.5
PSA (Ų)
0.61
QED
0
Ro5 Violations
5
Rot. Bonds
Drug Information
| Molecule Type | Unknown |
| Availability | Unknown |
| Chirality | Unknown |
Activity Summary
IC50 2 meas. best 6.49
Target Activity Profile
| Target | Type | Best pChEMBL | Mean pChEMBL | Best (nM) | # Data |
|---|---|---|---|---|---|
| Egl nine homolog 1 CHEMBL5697 | IC50 | 6.49 | 6.49 | 326.0 | 2 |
Activity Data Samples
Top measurements by pChEMBL value
| Target | Type | Rel. | Value | Units | pChEMBL | Assay | PubMed |
|---|---|---|---|---|---|---|---|
| Egl nine homolog 1 | IC50 | = | 326.0 | nM | 6.49 | Inhibition of FITC-HIF1alpha (556 to 574 residues) binding to PHD2 (181 to 426 r... | 32787144 |
| Egl nine homolog 1 | IC50 | = | 326.0 | nM | 6.49 | EGLN-1 Activity Assay : The EGLN-1 (or EGLN-3) enzyme activity is determined usi... | - |
Literature References
| PubMed | DOI | Target Context | # Activities |
|---|---|---|---|
| 32787144 | 10.1021/acs.jmedchem.0c01161 | Egl nine homolog 1 | 1 |
Data from ChEMBL 36 via Core Engine